210 related articles for article (PubMed ID: 37815603)
21. Hyaluronic acid-serum albumin conjugate-based nanoparticles for targeted cancer therapy.
Edelman R; Assaraf YG; Levitzky I; Shahar T; Livney YD
Oncotarget; 2017 Apr; 8(15):24337-24353. PubMed ID: 28212584
[TBL] [Abstract][Full Text] [Related]
22. Binding of ovarian cancer cells to immobilized hyaluronic acid.
Catterall JB; Gardner MJ; Jones LM; Turner GA
Glycoconj J; 1997 Aug; 14(5):647-9. PubMed ID: 9298699
[TBL] [Abstract][Full Text] [Related]
23. Membrane protein glycosylation and CD44 content in the adhesion of human ovarian cancer cells to hyaluronan.
Catterall JB; Jones LM; Turner GA
Clin Exp Metastasis; 1999; 17(7):583-91. PubMed ID: 10845557
[TBL] [Abstract][Full Text] [Related]
24. Molecular weight specific impact of soluble and immobilized hyaluronan on CD44 expressing melanoma cells in 3D collagen matrices.
Sapudom J; Ullm F; Martin S; Kalbitzer L; Naab J; Möller S; Schnabelrauch M; Anderegg U; Schmidt S; Pompe T
Acta Biomater; 2017 Mar; 50():259-270. PubMed ID: 27965172
[TBL] [Abstract][Full Text] [Related]
25. Heregulin-mediated ErbB2-ERK signaling activates hyaluronan synthases leading to CD44-dependent ovarian tumor cell growth and migration.
Bourguignon LY; Gilad E; Peyrollier K
J Biol Chem; 2007 Jul; 282(27):19426-41. PubMed ID: 17493932
[TBL] [Abstract][Full Text] [Related]
26. Roles and targeting of the HAS/hyaluronan/CD44 molecular system in cancer.
Karousou E; Misra S; Ghatak S; Dobra K; Götte M; Vigetti D; Passi A; Karamanos NK; Skandalis SS
Matrix Biol; 2017 May; 59():3-22. PubMed ID: 27746219
[TBL] [Abstract][Full Text] [Related]
27. Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis.
Gardner MJ; Catterall JB; Jones LM; Turner GA
Clin Exp Metastasis; 1996 Sep; 14(4):325-34. PubMed ID: 8878406
[TBL] [Abstract][Full Text] [Related]
28. Triptolide suppresses the in vitro and in vivo growth of lung cancer cells by targeting hyaluronan-CD44/RHAMM signaling.
Song JM; Molla K; Anandharaj A; Cornax I; O Sullivan MG; Kirtane AR; Panyam J; Kassie F
Oncotarget; 2017 Apr; 8(16):26927-26940. PubMed ID: 28460475
[TBL] [Abstract][Full Text] [Related]
29. Tumor-suppressive functions of 4-MU on breast cancer cells of different ER status: Regulation of hyaluronan/HAS2/CD44 and specific matrix effectors.
Karalis TT; Heldin P; Vynios DH; Neill T; Buraschi S; Iozzo RV; Karamanos NK; Skandalis SS
Matrix Biol; 2019 May; 78-79():118-138. PubMed ID: 29673760
[TBL] [Abstract][Full Text] [Related]
30. Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.
Tong JH; Ng DC; Chau SL; So KK; Leung PP; Lee TL; Lung RW; Chan MW; Chan AW; Lo KW; To KF
BMC Cancer; 2010 Jun; 10():253. PubMed ID: 20525238
[TBL] [Abstract][Full Text] [Related]
31. Low disabled-2 expression promotes tumor progression and determines poor survival and high recurrence of esophageal squamous cell carcinoma.
Wang WL; Chang WL; Yang HB; Wang YC; Chang IW; Lee CT; Chang CY; Lin JT; Sheu BS
Oncotarget; 2016 Nov; 7(44):71169-71181. PubMed ID: 27036032
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.
Jeong JY; Kang H; Kim TH; Kim G; Heo JH; Kwon AY; Kim S; Jung SG; An HJ
Cancer Lett; 2017 Feb; 386():168-178. PubMed ID: 27887917
[TBL] [Abstract][Full Text] [Related]
33. Versican induces a pro-metastatic ovarian cancer cell behavior which can be inhibited by small hyaluronan oligosaccharides.
Ween MP; Hummitzsch K; Rodgers RJ; Oehler MK; Ricciardelli C
Clin Exp Metastasis; 2011 Feb; 28(2):113-25. PubMed ID: 21153687
[TBL] [Abstract][Full Text] [Related]
34. Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma.
Lee SJ; Ghosh SC; Han HD; Stone RL; Bottsford-Miller J; Shen DY; Auzenne EJ; Lopez-Araujo A; Lu C; Nishimura M; Pecot CV; Zand B; Thanapprapasr D; Jennings NB; Kang Y; Huang J; Hu W; Klostergaard J; Sood AK
Clin Cancer Res; 2012 Aug; 18(15):4114-21. PubMed ID: 22693353
[TBL] [Abstract][Full Text] [Related]
35. X-ray irradiation induced Disabled-2 gene promoter de-methylation enhances radiosensitivity of non-small-cell lung carcinoma cells.
Ma S; Zhang WL; Leckey BD; Xu HT; Yang LH; Wang E
J Exp Clin Cancer Res; 2018 Dec; 37(1):315. PubMed ID: 30547821
[TBL] [Abstract][Full Text] [Related]
36. Disable 2, A Versatile Tissue Matrix Multifunctional Scaffold Protein with Multifaceted Signaling: Unveiling Role in Breast Cancer for Therapeutic Revolution.
Shah NN; Dave BP; Shah KC; Shah DD; Maheshwari KG; Chorawala MR
Cell Biochem Biophys; 2024 Apr; ():. PubMed ID: 38594547
[TBL] [Abstract][Full Text] [Related]
37. Cardiac Hyaluronan Synthesis Is Critically Involved in the Cardiac Macrophage Response and Promotes Healing After Ischemia Reperfusion Injury.
Petz A; Grandoch M; Gorski DJ; Abrams M; Piroth M; Schneckmann R; Homann S; Müller J; Hartwig S; Lehr S; Yamaguchi Y; Wight TN; Gorressen S; Ding Z; Kötter S; Krüger M; Heinen A; Kelm M; Gödecke A; Flögel U; Fischer JW
Circ Res; 2019 May; 124(10):1433-1447. PubMed ID: 30916618
[TBL] [Abstract][Full Text] [Related]
38. CD44 enhances invasion of basal-like breast cancer cells by upregulating serine protease and collagen-degrading enzymatic expression and activity.
Montgomery N; Hill A; McFarlane S; Neisen J; O'Grady A; Conlon S; Jirstrom K; Kay EW; Waugh DJ
Breast Cancer Res; 2012 May; 14(3):R84. PubMed ID: 22621373
[TBL] [Abstract][Full Text] [Related]
39. Disabled-2, a versatile tissue matrix multifunctional scaffold protein with multifaceted signaling: Unveiling its potential in the cancer battle.
Shah NN; Dave BP; Shah KC; Shah DD; Maheshwari KG; Chorawala MR; Parekh PS; Jani M
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; ():. PubMed ID: 38502243
[TBL] [Abstract][Full Text] [Related]
40. Aberrant hypermethylation and reduced expression of disabled-2 promote the development of lung cancers.
Xie XM; Zhang ZY; Yang LH; Yang DL; Tang N; Zhao HY; Xu HT; Li QC; Wang EH
Int J Oncol; 2013 Nov; 43(5):1636-42. PubMed ID: 24002585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
